Researchers Identify Zika Incubation Period and Optimal Testing Methods
April 25th 2017Two studies published in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal have outlined just how local and travel-related Zika cases differ, as well as which testing method is most sensitive to Zika virus RNA.
Yellow Fever: A Transcontinental Threat?
April 25th 2017The New England Journal of Medicine recently published two pieces on yellow fever. The first reports on the situation in the Americas, while the second recounts the case of a man from Angola who was found to be coinfected with yellow fever and Japanese encephalitis virus, although he reported no history of travel.
UCLA Study Deems UN's HIV Elimination Strategy for Sub-Saharan Africa Unfeasible
April 24th 2017Using statistical mapping strategies, UCLA researchers have found that the WHO and UNAIDS strategy to eliminate HIV in sub-Saharan Africa is not feasible because it doesn’t consider several important factors.
Perinatally-Infected HIV Youth Are Prone to Serious Health Events as They Age
April 21st 2017A recent study finds that children who are infected with HIV either just before or after birth are at much greater risk of experiencing serious health events—and even death—than children who are infected during adolescence.
National Transgender HIV Testing Day: Why It's Important to Know Your Status
April 18th 2017Each year, on April 18th, we recognize the importance of HIV testing and status awareness as well as prevention and treatment efforts among transgender individuals, a population particularly at risk for the virus.
Researchers Study MDRO Presence in Biofilms Collected From Hospitals in 4 Countries
April 17th 2017Researchers collected biofilms from several hospitals in four non-neighboring countries to determine if the persistence of multidrug-resistant organisms in biofilms on hospital surfaces was a worldwide problem.
Examining HCV Burden in EU and Measures to Eradicate it by 2030
April 17th 2017Researchers from the Center for Disease Analysis investigated the incidence of hepatitis C in the European Union (EU) and examined the measures that would be needed to achieve the World Health Organization’s ultimate goal of eradicating the disease by 2030.